Please login to the form below

Not currently logged in
Email:
Password:

ASBM

This page shows the latest ASBM news and features for those working in and with pharma, biotech and healthcare.

Novartis weighs in on biosimilar naming debate

Novartis weighs in on biosimilar naming debate

However, this process has been challenged in recent months by groups, such as the Alliance for Safe Biologic Medicines (ASBM), who argue that biosimilar medicines should have their own distinct scientific ... The ASBM, whose members include biologic drug

Latest news

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics